SEC Form 4 · accession 0001645627-17-000053
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 3, 2017
Accepted (ET)
May 5, 2017 · 11:41 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 3, 2017 | P | 1,000 | $0.0789 | A | 20,579,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,580,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,581,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,582,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,583,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,584,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,585,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,586,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,587,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.0788 | A | 20,588,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,589,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.0786 | A | 20,590,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,591,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.078 | A | 20,592,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.078 | A | 20,593,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.078 | A | 20,594,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.078 | A | 20,595,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.078 | A | 20,596,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.078 | A | 20,597,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.0768 | A | 20,598,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.077 | A | 20,599,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.077 | A | 20,600,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.077 | A | 20,601,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.077 | A | 20,602,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,603,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,604,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.0828 | A | 20,605,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.082 | A | 20,606,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.082 | A | 20,607,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.081 | A | 20,608,949 | D |
Table II — derivative securities
No Table II lines on this filing.